Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Micafungin (Mycamin ®) as Antifungal Prophylaxis Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease.

NCT02172768 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02172768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02172768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Micafungin (Mycamin ®) as Antifungal Prophylaxis Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease.
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
July 31, 2016
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease grade ii-iv, acute myeloid leucaemia, allogeneic stem cell transplant, myelo dysplastic syndrome